Partner Profile
CV Therapeutics | |
Location | Palo Alto, CA |
Organization Type | Health Care |
Percentage Green Power | 42% |
Organization-wide Purchase | Yes |
Partner Profile CV Therapeutics® is a biopharmaceutical company primarily focused on the discovery, development, and commercialization of new small molecule drugs for the treatment of cardiovascular diseases. CVT is committed to improving human health; since global warming is an issue that affects all of us, we decided to purchase "green" power to reduce our carbon dioxide emissions. As a consequence, the company purchases nearly 1.6 million kilowatt hours of renewably-generated electricity annually. CV Therapeutics has found that it costs very little to make a big impact, especially when a company funds the purchase of green power through energy efficiency project-derived savings. "Over the past six or seven years CV Therapeutics has continuously worked to improve the energy efficiency of its facilities. As a result, we've been able to cut our utilities costs and reinvest a portion of the savings into the purchase of green power. We feel this is a win for CVT and the environment," said Dan Spiegelman, Senior Vice President and Chief Financial Officer. As a result of its efforts to reduce carbon dioxide emissions, CVT has been publicly recognized by the City of Palo Alto and Sustainable Silicon Valley. Its employees feel a sense of pride in knowing they work for a company that buys green power. |